Aims/hypothesis Recently, hedgehog (Hh) was identified as a crucial player in adipose tissue development and energy expenditure. Therefore, we tested whether Hh ligands are regulated in obesity. Further, we aimed at identifying potential target cells of Hh signalling and studied the functional impact of Hh signalling on adipose tissue inflammation and glucose metabolism.
).
Results Desert Hh (DHH) and Indian Hh (IHH) are local Hh ligands, whereas Sonic Hh is not expressed in adipose tissue from mice or humans. In mice, obesity leads to a preferential upregulation of Hh ligands (Dhh) and signalling components (Ptch1, Smo and Gli1) in subcutaneous adipose tissue. Further, adipose tissue macrophages are Hh target cells owing to the expression of Hh receptors, such as Patched1 and 2. Conditional knockout of Smo (which encodes Smoothened, a mandatory Hh signalling component) in myeloid cells increases body weight and adipose tissue inflammation and attenuates glucose tolerance, suggesting an anti-inflammatory effect of Hh signalling. In humans, adipose tissue expression of DHH and serum IHH decrease with obesity and type 2 diabetes, which might be explained by the intake of metformin. Interestingly, metformin reduced Dhh and Ihh expression in mouse adipose tissue explants. Conclusions/interpretation Hh signalling in myeloid cells affects adipose tissue inflammation and glucose metabolism and may be a potential target to treat type 2 diabetes. Electronic supplementary material The online version of this article (doi:10.1007/s00125-017-4223-5) contains peer-reviewed but unedited supplementary material, which is available to authorised users.
Introduction
One of the major health problems in Western societies is an unbalanced energy metabolism, which increases the risk of obesity and associated pathologies including hypertension, coronary heart disease, stroke, several types of cancer and type 2 diabetes [1] . Obesity is associated with a chronic low-grade inflammation within adipose tissue and an increase in immune cells, specifically macrophages [2] [3] [4] . Adipose tissue macrophages (ATMs) accumulate around dying adipocytes and generate characteristic crown-like structures (CLS). In addition, the immune phenotype of ATMs in obesity shifts from an alternatively activated (M2) to a classically activated (M1) phenotype [5] . M1 macrophages secrete proinflammatory cytokines, such as IL-1β or TNFα [6] , and are therefore referred to as proinflammatory macrophages. Importantly, infiltration of ATMs is the strongest independent predictor of insulin resistance. Moreover, adipose tissue inflammation strongly correlates with hepatosteatosis [7, 8] .
In 1980, Nüsslein-Volhard and Wieschaus discovered the evolutionarily conserved hedgehog (Hh) gene [9] . Since then, Hh has been implicated in many fundamental processes in embryo development including cell growth, survival, fate and patterning [10] as well as in maintenance of adult stem cell niches [11] . Furthermore, dysregulation of Hh signalling contributes to various pathologies, most notably different kinds of cancers [12] , developmental disorders [13] and human syndromes, such as BardetBiedl syndrome [14] .
After binding of Hh ligands, the inhibitory association of the Patched receptor with its co-receptor Smoothened (SMO) is removed. Subsequently, GLI (GLI-Kruppel family member GLI1) transcription factors translocate to the nucleus and modulate specific target genes. Hh family ligands, including Sonic (SHH), Indian (IHH) and Desert hedgehog (DHH) require autoprocessive cleavage as well as post-translational modifications. In this context, the hedgehog acyltransferase (HHAT) is responsible for palmitoylation and subsequent secretion of Hh [15, 16] .
Hh signalling has recently been implicated in adipose tissue regulation [17] [18] [19] . For instance, adipocyte differentiation is inhibited in vitro and in vivo by Hh signalling [17, 18] . Hh represents a crucial element in adipose tissue development in mammals as fat specific Hh activation in mice led to a total loss of white (WAT), but not brown adipose tissue (BAT). Thus, WAT and BAT adipogenesis are differentially regulated by Hh [18] . Further, Hh signalling reprograms cellular metabolism toward a Warburg-like glycolytic state via an additional, non-canonical Hh signalling pathway [20] . In humans, the impact of dysfunctional Hh signalling is further displayed in the genetic disorder Bardet-Biedl syndrome, which is characterised by defects in multiple organ systems, truncal obesity and diabetes [21] .
The present study aimed to explore the regulation of Hh ligands and its signalling components in obesity. Our hypothesis is that dysregulation of Hh ligands could contribute to obesity-associated diseases, such as type 2 diabetes. Further, we aimed at identifying Hh target cells within adipose tissue to unravel an additional mechanism linking Hh dysregulation in obesity to type 2 diabetes.
Methods
Experimental animals Mice were maintained in the local animal facility with a 12 h light and dark cycle and with free access to food and water. For diet-induced obesity, male wild-type C57BL/6 J mice (from the animal facility at Leipzig University) were fed a high-fat diet (HFD; 60% energy from fat; Ssniff-Spezialdiäten; Soest, Germany) for 20 weeks, starting at 6 weeks of age. Control littermates were kept on a regular chow diet. Group assignment was blinded to the investigator. In addition, we used a transgene mouse model expressing a myeloid cell-specific deletion of the Smo gene, which encodes the hedgehog co-receptor SMO, generated and characterized by Y. Zavros (Department of Molecular and Cellular Physiology, University of Cincinnati, Cincinnati, Ohio, USA) as previously described [22] . Transgenic mice were generated by breeding mice bearing loxP sites flanking the exon 1 of the Smo gene to mice expressing a Cre recombinase from the Lysozyme M locus (LysMCre), resulting in an predominant recombination in myeloid cells, such as monocytes, macrophages and granulocytes. For these experiments, littermate controls of wild-type (Lys-Smo +/+ ), heterozygous (Lys-Smo +/− ) or knockout animals (Lys-Smo −/− ) were also used. HFD-feeding was performed as described above. Body weight was recorded weekly. Whole body composition (fat mass and lean mass) was determined by using EchoMRI700 (EchoMedical Systems, Houston, USA) on adult chow-fed littermates. Plasma variables were studied as described before [23] . All experiments were approved by the local authorities (Landesdirektion Leipzig).
Study participants Subcutaneous (abdomen) and visceral (omentum majus) fat biopsies were obtained from patients that underwent abdominal surgery for weight reduction, gastric banding, abdominal injuries, cholecystectomy or appendectomy at Leipzig University. Visceral fat area and the relative ratio of intra-abdominal visceral fat to the subcutaneous fat area using computed tomography (CT) scans at the level of L4-L5 was calculated as previously described [24] . In addition, blood and serum variables as well as insulin sensitivity were analysed as described in the electronic supplementary material (ESM) Methods section. Patients with severe conditions including generalised inflammation or end stage malignant diseases were excluded from the study. Clinical characteristics of the Leipzig cohort are given in ESM Table 1 . The numbers of individuals for specific analyses (indicated in brackets) may deviate from the entire study cohort, because only complete data sets were included. The study was approved by the Ethics Committee of the Leipzig University. All participants gave written informed consent before taking part in the study.
Gene expression analysis in mice and humans Gene expression analysis of mouse and human tissues was performed as described previously [24] [25] [26] . Primers for murine genes are listed in ESM Table 2 . Human target and housekeeping genes were amplified by specific TaqMan primer and probe assays (DHH, Hs00368306_m1, IHH, Hs00745531_s1; SHH, Hs00179843_m1; HHAT, Hs00911326_m1, H PR T 1, H s010 032 67_ m1; A p plied B iosyste m s, Darmstadt, Germany). HPRT1 was used as housekeeping gene.
ELISA of Hh ligands in serum and tissue Mouse samples were tested for serum and tissue levels of Hh ligands by using an appropriate ELISA kit for either human or mouse Hh ligands (Human and mouse IHH; both from Cusabio; Wuhan, China; catalogue no. CSB-E12007h and CSB-E16517m; and mouse DHH; EIAab Science; Wuhan, China; catalogue no. E1016m). For determination of Hh tissue levels, protein was extracted by RIPA buffer supplemented with 1% PMSF and 1% protease-inhibitor-cocktail (Sigma-Aldrich; Taufkirchen, Germany). Protein content was determined using the BCA protein assay (Pierbo Science; Bonn, Germany). 5 μg of protein homogenate or 100 μl of sera were applied and measured.
Immunofluorescence and H&E staining Mouse adipose tissue was fixed in formaldehyde and subsequently cryoor paraffin-embedded as described previously [4, 27] . Primary antibodies anti-Patched1, anti-Patched2 (both 1:5 0; G ene Te x) , an d an t i -SM O (1 : 50; A bc am ; Cambridge, UK), anti-Mac-2 (1:1000; Cedarlane; Burlington, ON, Canada) and anti-PerilipinA (1:200; Abcam), were incubated overnight at 4°C followed by fluorochrome-conjugated secondary antibodies (1:200; Invitrogen; Karlsruhe, Germany). Finally, DAPI (1:10,000; Sigma-Aldrich; Deisenhofen, Germany) was used for nuclear counterstaining. Images were taken using an Olympus BX51 epifluorescence microscope (Olympus; Hamburg, Germany). For control stainings, primary antibodies were omitted and sections were stained in parallel as described above. H&E staining of adipose and liver tissues was performed following standard routines. Adipocyte size and CLS density were quantified as described previously [8] . For detection of SMO on human paraffin sections, the Dako REAL EnVision Detection System (Dako) was used according to the manufacturer's protocol.
Insulin sensitivity and glucose tolerance test Insulin sensitivity tests or glucose tolerance tests on HFD-fed mice were performed as described previously [23] . The investigator was blinded to the genotype.
Live imaging of migration of ATMs in living tissue Staining of ATMs using AlexaFluor647-conjugated isolectin B4 (IB4) from Griffonia simplicifolia (ThermoFisher Scientific; Dreieich, Germany) and subsequent live imaging of adipose tissue explants were performed as described before in detail [28] . Images were obtained every 15 min and dynamic parameters of ATMs (5 movies per genotype) were validated in an unbiased, automated fashion using the Trackmate plugin from Fiji software 2.0 [29] .
Cultivation of adipose tissue explants and drug treatment
Epididymal adipose tissue of adult male mice was used to generate organotypic adipose tissue cultures (explants). Briefly, mice were killed, the fat pad was dissected under sterile conditions and further cut into 1 mm 3 pieces using a sterile razor blade. Explants were cultured for 24 h in RPMI medium (Sigma-Aldrich) supplemented with 1% insulin-transferrin-selenium mixture and antibiotics (100 U/ml penicillin and streptomycin; all reagents from Sigma-Aldrich) at 5% CO 2 , 21% O 2 and 37°C. Drug treatment was performed for 24 h with either 1 mmol/l metformin, 10 μmol/l atorvastatin or 10 μmol/l simvastatin (all Sigma-Aldrich). Activation of simvastatin was performed as previously described [30] .
Isolation and cultivation of primary hepatocytes and RNA interference Isolation and cultivation of primary hepatocytes was performed as previously described [26] . Details of this procedure as well as of knockdown of Hhat by RNA interference are given in the ESM Methods section.
Statistical analysis Data are presented as means ± SEM of at least three animals evaluated by the Student-Newman-Keuls method for multiple comparisons, the Student's t test or Mann-Whitney U test (GraphPad Prism; GraphPad Software, La Jolla, CA, USA). For the RNA interference experiments, a paired Student's t test was used. Linear regression was confirmed using GraphPad software for human data and correlation analyses were performed according to Pearson. All data were checked for statistical outliers using the Grubbs' test. A p value <0.05 was considered to be statistically significant.
Results
Hh ligands are increased in mouse obesity To unravel the functional importance of Hh ligands in obesity, we first studied the expression profile of the three known Hh ligands. In mouse adipose tissue, Dhh and Ihh were expressed (Fig. 1a, b) , whereas Shh mRNA was not detectable in epididymal or subcutaneous adipose tissue (Fig. 1a, b and  ESM Fig. 1 ). In epididymal adipose tissue, we were unable to detect differential expression of Hh ligands between lean and obese littermates, but in subcutaneous adipose tissue Dhh mRNA was increased by twofold in obese mice (Fig. 1b) . We performed ELISA analysis from tissue extracts for exact quantification of Hh tissue abundance in different tissues as well as in the serum. Interestingly, adipose tissue and serum levels of DHH were 15-and 40-fold higher, respectively, compared with IHH. Of note, both circulating Hh ligands were significantly more abundant in serum and subcutaneous adipose tissue of obese mice, compared with lean littermates (Fig. 1c, d ). We further studied the expression of Hhat, which encodes an enzyme responsible for secretion of Hh ligands [15, 16] . Indeed, Hhat mRNA was upregulated in epididymal and subcutaneous adipose tissue from obese mice by twofold (Fig. 1e) . As proof of principle, we knocked down Hhat by RNA interference in hepatocytes, which mainly express IHH [31] , and verified that Hh secretion depends on Hhat expression (ESM Fig 2) .
Hedgehog receptors are expressed by ATMs We next studied the gene expression of Hh signalling components in adipose tissue from lean and obese mice. Interestingly, as for Hh ligands, we found a depot-specific regulation for Hh signalling components at the mRNA level. In epididymal adipose tissue of obese mice, we found a non-significant downregulation of these components [17, 32] . However, in subcutaneous adipose tissue we found a significant increase of Hh signalling components (Ptch1, Smo and Gli1) in obesity (Fig. 2a-c) , as also shown for Hh ligands (Fig. 1b) . Using immunofluorescence we could also detect Hh responsive cells in subcutaneous and epididymal adipose tissue from obese mice. Interestingly, the vast majority of Hh receptor expression (Patched1, Patched2 and SMO) was found in focal spots of inflammation around dying adipocytes, so-called CLS. Accordingly, co-staining of the macrophage marker Mac-2 confirmed the expression of Hh receptors by ATMs ( Fig. 2d; arrows) . Further, in human adipose tissue sections from obese individuals, SMO could also be detected in CLS, whereas SMO staining was almost absent in adipose tissue from lean individuals (Fig. 2e) . Hence, our data indicate that ATMs are the preferential target of Hh signalling in adipose tissue from obese mice and humans.
Deficiency of Hh signalling in myeloid cells impacts on body weight and glucose metabolism Next, we used a conditional knockout model to test the effect of impaired Hh signalling in ATMs in obesity by deletion of the gene encoding the mandatory Hh co-receptor SMO in myeloid cells (Lys-Smo). Lys-Smo mice were generated and characterised in detail by Schumacher et al [22] . Of note, adult Lys-Smo rather than lean mass (ESM Fig. 3c, d ). In particular, the weight of epididymal adipose tissue was increased in these animals (ESM Fig. 3e, f) , suggesting visceral adiposity. However, these alterations did not impact on systemic glucose tolerance or insulin sensitivity in chow-fed animals (ESM Fig. 3g, h ). After 20 weeks of HFD all genotypes gained approximately 165% of initial body weight (Table 1) , resulting in a significantly higher body weight of Lys-Smo
, compared with Lys-Smo +/+ (Table 1 and Fig. 3a, b) . In line with this, average adipocyte diameter was increased in subcutaneous (Fig. 3c) . Importantly, we also found more hypertrophic adipocytes (diameter >100 μm) in subcutaneous and epididymal adipose tissue from obese Lys-Smo −/− mice (ESM Fig. 4a-c Fig. 4d ). In addition, plasma insulin was also significantly increased in HFD-fed Lys-Smo −/− mice (Fig. 3h) . Most importantly, insulin sensitivity and glucose tolerance tests were performed and Lys-Smo −/− animals exhibited impaired glucose tolerance, compared with Lys-Smo +/+ after HFD (Fig. 3i, j) .
Deficiency of Hh signalling in myeloid cells aggravates adipose tissue inflammation
We then studied the impact of SMO deficiency in myeloid cells on adipose tissue inflammation. We found a significant increase of CLS in epididymal adipose tissue of Lys-Smo −/− mice after 20 weeks of HFD (Fig. 4a, b) . Interestingly, gene expression analysis also revealed changes of inflammatory markers in adipose tissue of obese Lys-Smo −/− mice. In subcutaneous adipose tissue, Cd68 was upregulated as a macrophage marker, whereas in epididymal adipose tissue marker genes of . Macrophages and blood vessels are stained using IB4 and adipocytes are stained with Bodipy. Migration analysis is presented for IB4 staining of Lys-Smo −/− and Lys-Smo +/+ over 6 h (videos are available as ESM). (f, g) Diagrams summarise average macrophage displacement from the starting point (f) and mean migration velocity (g) (5 movies per genotype of four independent experiments). Scale bars are 100 μm. *p < 0.05, **p < 0.01 and ***p < 0.001 anti-inflammatory M2 polarisation were significantly downregulated (Fig. 4c, d) . Further, SMO deficiency in myeloid cells also impacted on dynamic parameters of adipose tissue inflammation as indicated by an elevated migration behaviour of ATMs in obese Lys-Smo −/− mice, compared with littermate control mice ( Fig. 4e-g ; ESM Videos 1 and 2).
Hh ligands are altered in human obesity Next, we studied paired visceral and subcutaneous adipose tissue samples from 283 humans. As in mice, IHH and DHH were expressed in visceral and subcutaneous adipose tissue of humans (Fig. 5a, b) , whereas SHH was not detectable. In line with this, the expression of SMO could also exclusively be detected by ATMs in human CLS (Fig. 2e) and DHH expression was preferentially found in subcutaneous adipose tissue (Fig. 5d) . In contrast to mice, both Hh ligands and HHAT decreased with increasing BMI, but only the decline of DHH and HHAT mRNA reached statistical significance (Fig. 5a-c) . Furthermore, in our cohort highly significant negative correlations of DHH and HHAT with other obesity variables, such as body weight, waist and hip circumferences, percentage of body fat and fat area were found (Tables 2  and 4 ). In contrast, IHH expression did not correlate with the vast majority of obesity variables (Table 3 ). According to the reduction of HHAT mRNA in human obesity, analysis of human serum samples also revealed a significant reduction of circulating Hh ligands in morbidly obese compared with lean and overweight individuals (Fig. 5e) . Interestingly, morbidly obese individuals (BMI >40 kg/m 2 ) with normal glucose metabolism (HbA 1c <6%) exhibited significantly higher serum levels of IHH, compared with patients with type 2 diabetes (HbA 1c >7%; Fig. 5f ). In line with this, indicators for insulin resistance within our cohort (glucose infusion rate during euglycaemic-hyperinsulinaemic clamp tests, HbA 1c , fasting plasma insulin [FPI] and blood glucose after glucose challenge) correlated negatively with HHAT expression, whereas indicators of a metabolically healthy obese phenotype, such as HDL-cholesterol and adiponectin, correlated positively with HHAT mRNA (Table 4) .
We further hypothesised that the unexpected decrease of Hh ligands in human obesity and type 2 diabetes could be related to environmental factors, such as drug intake. Therefore, we studied the impact of atorvastatin, simvastatin and metformin on Dhh, Ihh and Hhat mRNA expression in murine adipose tissue explants; statins and metformin represent first line treatment of hypercholesterolemia or type 2 diabetes, respectively [33] . Most interestingly, metformin decreased Dhh and Ihh expression, without affecting Hhat or Casp3 (encoding caspase 3) expression (data not shown), therefore excluding a cell-toxic effect (Fig. 5g-i) . 
Discussion
Hh has recently been suggested as a potential drug target owing to its potential to lower blood glucose and inhibit adipose tissue development [18, 20] . These studies were performed using genetic mouse models or pharmacological approaches to inhibit or stimulate Hh signalling in adipose tissue, respectively. However, the physiological regulation of Hh ligands in obesity and type 2 diabetes is ill defined. We here report that DHH and IHH are the preferential local Hh ligands in adipose tissue. Further, subcutaneous adipose tissue is more prone to obesity-associated regulation of the Hh pathway than visceral adipose tissue. In addition, extracellular Hh abundance depends on Hhat expression, rather than on Dhh or Ihh gene expression, as shown by Hhat knockdown in hepatocytes. HHAT is an enzyme involved in secretion of Hh ligands [15, 16] , and this enzyme is also upregulated in epididymal adipose tissue from obese mice. In line with this, Intercorrelation between Vis DHH and Sc DHH mRNA: r = 0.094; p = 0.110
After adjustment for BMI, age and sex all correlations are gone ALT, alanine aminotransferase; AST, aspartate aminotransferase; CRP, C-reactive protein; FPG, free plasma glucose; FPI, free plasma insulin; FT3, free triiodothyronine; GGT, γ-glutamyltransferase; GIR, glucose infusion rate; Sc, subcutaneous; Vis, visceral [38] . However, in contrast to other anti-inflammatory markers, Il-13 was elevated in epididymal adipose tissue; Il-13 is usually increased in adipose tissue from obese mice [39, 40] and might be responsible for obesity-associated ATM proliferation (unpublished data). Next, we aimed at extending our knowledge on expression and regulation of Hh ligands in obesity to human tissue. First, we found that in human adipose tissue DHH and IHH were also expressed, whereas we were unable to detect SHH. Notably, in sharp contrast to mice, DHH, IHH and HHAT were downregulated with increasing BMI. This was also verified at the protein level for circulating IHH. IHH was significantly decreased in serum from obese and diabetic participants, potentially due to a decrease in HHAT expression in human obesity. Importantly, HHAT upregulation is the best correlate of metabolic recovery after bariatric surgery in humans [41] .
However, the reason for the contrary regulation of Hh ligands in mouse and human obesity is unknown. In general, the physiological regulation of Hh ligands is poorly understood. Notably, cholesterol represents an essential component of post-translational modification of Hh [42] and pharmacological inhibition of cholesterol biosynthesis decreases Hh expression [43] . Further, the glucose-lowering drug metformin also impacts on Hh expression [44, 45] . In our study, statin treatment did not alter Hh expression, but metformin significantly reduces Dhh and Ihh expression in All data were log transformed (log 10 ) and data are shown as correlation coefficient (r) and p value (p). *p < 0.05, **p < 0.01, ***p < 0.001
Intercorrelation between Vis HHAT and Sc HHAT mRNA: r = 0.467; p < 0.0001
After adjustment for BMI, age and sex all correlations are gone ALT, alanine aminotransferase; AST, aspartate aminotransferase; CRP, C-reactive protein; FPG, free plasma glucose; FPI, free plasma insulin; FT3, free triiodothyronine; GGT, γ-glutamyltransferase; GIR, glucose infusion rate; Sc, subcutaneous; Vis, visceral adipose tissue explants. Since the vast majority of our diabetes patients regularly take metformin, metformin could counteract a diabetes-induced upregulation of Hh ligands. In addition, intrinsic differential relationships between the expression of specific genes in adipose tissue from mice or humans were reported in systematic comparisons of developmental genes [46] . Therefore, we cannot exclude intrinsic differences between humans and mice in the regulation of Hh expression.
To address this hypothesis, further human studies including pharmacotherapy-naive individuals are required. We here show that inhibition of Hh signalling in myeloid cells increases body weight, aggravates adipose tissue inflammation and impairs glucose metabolism in mice. Therefore, a decrease in local and circulating Hh ligands within adipose tissue from obese patients could contribute to metabolic dysfunction and may represent a novel target to treat adipose tissue dysfunction and type 2 diabetes.
